Skip to main content
. 2022 Jul 23;27(15):4723. doi: 10.3390/molecules27154723

Table 23.

Five-component synthesis of dihydropyrano[2,3-c]pyrazoles 88 and their in vitro antibacterial activity against four bacterial strains.

graphic file with name molecules-27-04723-i037.jpg
Compound Ar Yield of 88 (%) Antibacterial Activity of Compounds 88 (Zone of Inhibition (in mm) at conc. 100 mg/mL after 24 h)
Gram-Positive Bacteria Gram-Negative Bacteria
BS SA EC PA
88a 4-MeOC6H4 81 -- -- -- --
88b 4-MeC6H4 85 3.8 3.0 2.9 2.6
88c 4-HOC6H4 84 9.1 8.8 8.7 8.0
88d Ph 82 4.9 4.6 4.5 4.3
88e 4-FC6H4 80 18.8 17.1 17.5 15.2
88f 3-FC6H4 83 13.6 12.2 10.9 9.6
88g 3-HOC6H4 84 5.6 5.1 5.6 5.6
88h 2-HOC6H4 86 7.5 7.4 6.3 7.0
88i 2-MeC6H4 83 -- 2.8 -- --
88j 2-MeOC6H4 89 -- -- -- --
88k 2-ClC6H4 88 11.4 10.4 10.2 9.1
88l 4-ClC6H4 82 15.6 13.1 12.7 11.0
88m 4-BrC6H4 84 9.8 9.3 8.9 8.2
88n 4-NO2C6H4 83 16.2 15.2 15.3 13.7
Tetracycline a -- -- 19.4 18.1 16.8 14.2

BS (Bacillus subtilis), SA (Staphylococcus aureus), EC (Escherichia coli), PA (Pseudomonas aeruginosa). a Standard drug for this study.